Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial.
Lancet. 2012 May 19;379(9829):1879-86. doi: 10.1016/S0140-6736(12)60651-5. Epub 2012 May 16.
Lancet. 2012.
PMID: 22595799
Free article.
Clinical Trial.
Outcome of uterine sarcoma patients treated with pazopanib: A retrospective analysis based on two European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) clinical trials 62043 and 62072.
Benson C, Ray-Coquard I, Sleijfer S, Litière S, Blay JY, Le Cesne A, Papai Z, Judson I, Schöffski P, Chawla S, Gil T, Piperno-Neumann S, Marréaud S, Dewji MR, van der Graaf WTA.
Benson C, et al. Among authors: dewji mr.
Gynecol Oncol. 2016 Jul;142(1):89-94. doi: 10.1016/j.ygyno.2016.03.024. Epub 2016 Apr 29.
Gynecol Oncol. 2016.
PMID: 27012429
Clinical Trial.
Item in Clipboard
Early phase I data on an irreversible pan-erb inhibitor: CI-1033. What did we learn?
Dewji MR.
Dewji MR.
J Chemother. 2004 Nov;16 Suppl 4:44-8. doi: 10.1179/joc.2004.16.Supplement-1.44.
J Chemother. 2004.
PMID: 15688609
Review.
Item in Clipboard
Cite
Cite